These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 23972722)
1. Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: results of the quality assurance program of the randomized trial SAKK 09/10. Sassowsky M; Gut P; Hölscher T; Hildebrandt G; Müller AC; Najafi Y; Kohler G; Kranzbühler H; Guckenberger M; Zwahlen DR; Azinwi NC; Plasswilm L; Takacs I; Reuter C; Sumila M; Manser P; Ost P; Böhmer D; Pilop C; Aebersold DM; Ghadjar P Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):534-41. PubMed ID: 23972722 [TBL] [Abstract][Full Text] [Related]
2. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT. Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999 [TBL] [Abstract][Full Text] [Related]
3. A knowledge-based approach to improving and homogenizing intensity modulated radiation therapy planning quality among treatment centers: an example application to prostate cancer planning. Good D; Lo J; Lee WR; Wu QJ; Yin FF; Das SK Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):176-81. PubMed ID: 23623460 [TBL] [Abstract][Full Text] [Related]
4. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Wolff D; Stieler F; Welzel G; Lorenz F; Abo-Madyan Y; Mai S; Herskind C; Polednik M; Steil V; Wenz F; Lohr F Radiother Oncol; 2009 Nov; 93(2):226-33. PubMed ID: 19765846 [TBL] [Abstract][Full Text] [Related]
5. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy. Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189 [TBL] [Abstract][Full Text] [Related]
6. Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer. Boustani J; Rivin Del Campo E; Blanc J; Peiffert D; Benezery K; Pereira R; Rio E; Le Prisé E; Créhange G; Huguet F Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):329-337. PubMed ID: 31299242 [TBL] [Abstract][Full Text] [Related]
7. Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer. Guckenberger M; Meyer J; Baier K; Vordermark D; Flentje M Radiat Oncol; 2006 Sep; 1():34. PubMed ID: 16956403 [TBL] [Abstract][Full Text] [Related]
8. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study. Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271 [TBL] [Abstract][Full Text] [Related]
9. Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10. Ghadjar P; Hayoz S; Bernhard J; Zwahlen DR; Hölscher T; Gut P; Guckenberger M; Hildebrandt G; Müller AC; Plasswilm L; Papachristofilou A; Stalder L; Biaggi-Rudolf C; Sumila M; Kranzbühler H; Najafi Y; Ost P; Azinwi NC; Reuter C; Bodis S; Kaouthar K; Wust P; Thalmann GN; Aebersold DM J Clin Oncol; 2015 Dec; 33(35):4158-66. PubMed ID: 26527774 [TBL] [Abstract][Full Text] [Related]
10. Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial. Jaccard M; Zilli T; Dubouloz A; Escude L; Jorcano S; Linthout N; Bral S; Verbakel W; Bruynzeel A; Björkqvist M; Minn H; Tsvang L; Symon Z; Lencart J; Oliveira A; Ozen Z; Abacioglu U; Pérez-Moreno JM; Rubio C; Rouzaud M; Miralbell R Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):1047-1054. PubMed ID: 32535161 [TBL] [Abstract][Full Text] [Related]
11. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy. Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391 [TBL] [Abstract][Full Text] [Related]
12. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer. Davidson MT; Blake SJ; Batchelar DL; Cheung P; Mah K Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1550-8. PubMed ID: 21543164 [TBL] [Abstract][Full Text] [Related]
13. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer. Chera BS; Vargas C; Morris CG; Louis D; Flampouri S; Yeung D; Duvvuri S; Li Z; Mendenhall NP Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):994-1002. PubMed ID: 19619961 [TBL] [Abstract][Full Text] [Related]
14. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk. Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434 [TBL] [Abstract][Full Text] [Related]
15. Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer. Hysing LB; Skorpen TN; Alber M; Fjellsbø LB; Helle SI; Muren LP Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1496-503. PubMed ID: 18538493 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of geometrical uncertainties on localized prostate radiotherapy of patients with bilateral metallic hip prostheses using 3D-CRT, IMRT and VMAT: A planning study. Soda R; Hatanaka S; Hariu M; Shimbo M; Yamano T; Nishimura K; Kondo S; Utsumi N; Takahashi T J Xray Sci Technol; 2020; 28(2):243-254. PubMed ID: 31985486 [TBL] [Abstract][Full Text] [Related]
17. Dosimetric analysis of three-dimensional conformal radiotherapy, intensity-modulated radiotherapy-step and shoot, helical tomotherapy, and volumetric modulated arc therapy in prostate cancer radiotherapy. Gozal F; Gondhowiardjo SA; Kodrat H; Wibowo WE J Cancer Res Ther; 2021; 17(4):893-900. PubMed ID: 34528538 [TBL] [Abstract][Full Text] [Related]
18. Regional hyperthermia and moderately dose-escalated salvage radiotherapy for recurrent prostate cancer. Protocol of a phase II trial. Müller AC; Zips D; Heinrich V; Lamprecht U; Voigt O; Burock S; Budach V; Wust P; Ghadjar P Radiat Oncol; 2015 Jul; 10():138. PubMed ID: 26152590 [TBL] [Abstract][Full Text] [Related]
19. Simplified intensity-modulated arc therapy for dose escalated prostate cancer radiotherapy. Bauman G; Gete E; Chen JZ; Wong E Med Dosim; 2004; 29(1):18-25. PubMed ID: 15023389 [TBL] [Abstract][Full Text] [Related]
20. Postoperative radiotherapy for prostate cancer : evaluation of target motion and treatment techniques (intensity-modulated versus conformal radiotherapy). Pinkawa M; Siluschek J; Gagel B; Piroth MD; Demirel C; Asadpour B; Eble MJ Strahlenther Onkol; 2007 Jan; 183(1):23-9. PubMed ID: 17225942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]